Action Potential Venture Capital Ltd. — Full Portfolio
6 tracked investments · listed companies and verified rows first
Clinical-stage company developing novel treatment for recurrent high-grade gliomas
HealthtechChanhassen, US
Jeremy Ling(Executive Officer)Steve Weiner(Executive Officer)Vijay Agarwal(Executive Officer, Director)William Davis(Executive Officer, Director)
BoardKlaus Veitinger(Director)Imran Eba(Executive Officer)
Board seatJuan-Pablo Mas· per SEC Form D · $67M raise · filed Jul 2026
San Mateo, US
Board seatJuan-Pablo Mas· per SEC Form D · $51.1M raise · filed Dec 2024
Exo is a company backed by leading venture capital and corporate investors focused on innovative technologies, with particular emphasis on healthcare, bioelectronic medicines, materials science, and deep technology solutions.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Board seatJuan-Pablo Mas· per SEC Form D · $10M raise · filed May 2025
Neuspera develops an integrated sacral neuromodulation system for treating urinary urge incontinence, using a smart implanted neurostimulator paired with a wireless external battery.
BiotechHealthtechMedical DevicesSan Jose, US
Milton M. Morris(Executive Officer, Director)
Board seatImran Eba· per SEC Form D · $79.6M raise · filed Jun 2021
HealthtechBloomington, US
Greg Plamondon(Executive Officer)Kristin Caplice(Executive Officer)Barry Regan(Executive Officer, Director)James Schuermann(Director, Executive Officer)Geoffrey Kinghorn(Director)
Board seatJuan-Pablo Mas· per SEC Form D · $30M raise · filed Nov 2025
SetPoint Medical develops an implantable wireless device that stimulates the vagus nerve to reduce inflammation and treat rheumatoid arthritis through a neuroimmune modulation approach.
BiotechHealthtechMedical DevicesValencia, US
Board seatJuan-Pablo Mas· per SEC Form D · $115.5M raise · filed Oct 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.